Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pittman

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Annals of the American Thoracic Society|October 9, 2024
Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic FibrosisBreAnna Kinghorn, Margaret Rosenfeld, Erin Sullivan, et al.
Plos One|November 18, 2022
Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort studyA Cozette Killian, Rhiannon D Reed, M Chandler McLeod, et al.
Pediatric Pulmonology|September 18, 2025
Airway Disease Progression on Chest Computed Tomography in Children With Primary Ciliary DyskinesiaBreAnna Kinghorn, Federico Mollica, Daan Caudri, et al.
The Lancet. Respiratory Medicine|January 5, 2025
Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trialJordana E Hoppe, Ajay S Kasi, Jessica E Pittman, et al.
Annals of the American Thoracic Society|April 13, 2016
Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and AdolescentsMargaret W Leigh, Thomas W Ferkol, Stephanie D Davis, et al.
Virchows Archiv : an International Journal of Pathology|January 4, 2021
Interobserver agreement and the impact of mentorship on the diagnosis of inflammatory bowel disease-associated dysplasia among subspecialist gastrointestinal pathologistsLindsay Alpert, Namrata Setia, Huaibin Mabel Ko, et al.
Annals of the American Thoracic Society|November 28, 2022
Airway Disease in Children with Primary Ciliary Dyskinesia: Impact of Ciliary Ultrastructure Defect and GenotypeBreAnna Kinghorn, Margaret Rosenfeld, Erin Sullivan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 23, 2021
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapyDave P Nichols, Scott H Donaldson, Carla A Frederick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2020
Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient OutcomeManish A Shah, Peter Enzinger, Andrew H Ko, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 24, 2022
Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GISarah Jane Schwarzenberg, Phuong T Vu, Michelle Skalland, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Annals of the American Thoracic Society|October 9, 2024
Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic FibrosisBreAnna Kinghorn, Margaret Rosenfeld, Erin Sullivan, et al.
Plos One|November 18, 2022
Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort studyA Cozette Killian, Rhiannon D Reed, M Chandler McLeod, et al.
Pediatric Pulmonology|September 18, 2025
Airway Disease Progression on Chest Computed Tomography in Children With Primary Ciliary DyskinesiaBreAnna Kinghorn, Federico Mollica, Daan Caudri, et al.
The Lancet. Respiratory Medicine|January 5, 2025
Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trialJordana E Hoppe, Ajay S Kasi, Jessica E Pittman, et al.
Annals of the American Thoracic Society|April 13, 2016
Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and AdolescentsMargaret W Leigh, Thomas W Ferkol, Stephanie D Davis, et al.
Virchows Archiv : an International Journal of Pathology|January 4, 2021
Interobserver agreement and the impact of mentorship on the diagnosis of inflammatory bowel disease-associated dysplasia among subspecialist gastrointestinal pathologistsLindsay Alpert, Namrata Setia, Huaibin Mabel Ko, et al.
Annals of the American Thoracic Society|November 28, 2022
Airway Disease in Children with Primary Ciliary Dyskinesia: Impact of Ciliary Ultrastructure Defect and GenotypeBreAnna Kinghorn, Margaret Rosenfeld, Erin Sullivan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 23, 2021
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapyDave P Nichols, Scott H Donaldson, Carla A Frederick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2020
Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient OutcomeManish A Shah, Peter Enzinger, Andrew H Ko, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 24, 2022
Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GISarah Jane Schwarzenberg, Phuong T Vu, Michelle Skalland, et al.
Pageof 22